Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Leafy Tunnel is a venture capital firm established in England and Wales, registered under number 13312326. The firm focuses on investing in alternative medicine, particularly in the fields of medicinal cannabis and psychedelics. Leafy Tunnel aims to support the growth of companies engaged in research, development, and commercialization within these sectors.
Currently, Leafy Tunnel operates with a team of four key members and targets the European market for investment opportunities. The firm emphasizes ethical and sustainable practices in its investment strategy, ensuring that its portfolio aligns with rigorous analysis and honest feedback. The firm is positioned to capitalize on the growing interest in alternative medicine, particularly as societal attitudes shift towards acceptance and legalization.
Leafy Tunnel invests primarily in the alternative medicine sector, with a specific focus on medicinal cannabis and psychedelics. The firm targets companies that address critical issues such as pain disorders, substance abuse, anxiety, depression, and other mental health challenges. Their investment strategy is rooted in ethical and sustainable practices, reflecting a commitment to responsible investing.
Geographically, Leafy Tunnel concentrates on the European market, seeking to build a diverse portfolio of companies that are innovating in the healthcare space. The firm values rigorous analysis and honest feedback, which guides its investment decisions and relationships with founders.
Nikolay Tretiyakov - Co-Founding Partner. Nikolay has extensive experience in venture capital and has been instrumental in establishing Leafy Tunnel's focus on alternative medicine.
Bek Nurgazy - Co-Founding Partner. Bek brings a wealth of knowledge in investment strategies and has played a key role in shaping the firm's ethical investment approach.
Andrey Makiyevskiy - Principal. Andrey specializes in identifying promising startups in the healthcare sector and has a strong background in venture capital.
Dennis Tran - Principal. Dennis focuses on operational support for portfolio companies, leveraging his expertise to help them scale effectively.
To pitch Leafy Tunnel, founders should send an email to info@leafytunnel.com. A concise pitch deck that includes the business model, market opportunity, and ethical considerations is essential. Response times may vary, so patience is advised.
What are Leafy Tunnel's investment criteria?
Leafy Tunnel focuses on companies in the alternative medicine sector, particularly those involved in medicinal cannabis and psychedelics. They look for businesses that address pain disorders, substance abuse, and mental health issues.
How can I pitch to Leafy Tunnel?
Founders can reach out via email at info@leafytunnel.com. A well-prepared pitch deck that outlines the business model, market opportunity, and ethical considerations is recommended.
What makes Leafy Tunnel different from other VCs?
Leafy Tunnel emphasizes ethical and sustainable investment practices, focusing on rigorous analysis and honest feedback. Their commitment to alternative medicine sets them apart in the venture capital landscape.
What is Leafy Tunnel's geographic focus?
The firm primarily targets the European market for its investments, seeking opportunities that align with its focus on alternative medicine.
What is the typical check size for investments?
Specific check sizes are not disclosed, but the firm is known to invest in early-stage companies within its focus sectors.
What kind of support does Leafy Tunnel provide post-investment?
Leafy Tunnel is committed to providing honest feedback and support to its portfolio companies, helping them navigate challenges and grow sustainably.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.